Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

Background. The role of neoadjuvant chemotherapy (NACT) in luminal HER2-negative breast cancer (BC) remains highly controversial due to the lack of reliable predictors of drug therapy efficacy.Objective: to evaluate the effectiveness of NACT in patients with aggressive luminal HER2-negative BC and t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: D.  A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I.  P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov
Formato: Artigo
Idioma:Russo
Publicado: ABV-press 2022-01-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Assuntos:
breast cancer
luminal her2-negative subtype
predictor factors for reaching pcr
residual pathomorphological stage of yptn
residual tumor burden according to the rcb system
tils
erlow tumor expression
her low tumor expression
Acceso en liña:https://ojrs.abvpress.ru/ojrs/article/view/894
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares